Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Bone Regeneration Induced by Strontium Folate Loaded Biohybrid Scaffolds

Martín-Del-Campo M., Sampedro JG., Flores-Cedillo ML., Rosales-Ibañez R., Rojo L.

Narrative Review, published in Molecules (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Molecules (2019)
Reported sample size
—
Source database
Europe PMC
PMID
31035627
PMCID
PMC6539601
DOI
10.3390/molecules24091660
Citations
14

Abstract (original English)

Nowadays, regenerative medicine has paid special attention to research (in vitro and in vivo) related to bone regeneration, specifically in the treatment of bone fractures or skeletal defects, which is rising worldwide and is continually demanding new developments in the use of stem cells, growth factors, membranes and scaffolds based on novel nanomaterials, and their applications in patients by using advanced tools from molecular biology and tissue engineering. Strontium (Sr) is an element that has been investigated in recent years for its participation in the process of remodeling and bone formation. Based on these antecedents, this is a review about the Strontium Folate (SrFO), a recently developed non-protein based bone-promoting agent with interest in medical and pharmaceutical fields due to its improved features in comparison to current therapies for bone diseases.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Bone and BonesStem CellsDental PulpAnimalsHumansStrontiumVitamin B 12Folic AcidVitamin B 6Biocompatible Materials

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.